Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of fluconazole treatment in premature and full-term newborns
2013-003611-21Phase 4Completed
- Sponsor
- Karolinska Institutet
- Start
- Oct 2013
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fluconazole and ibuprofen in mycoses and patent ductus arteriosus (PDA) (4 arms), sponsored by Karolinska Institutet. Primary endpoint: Urinary secretion of thromboxane A2 and prostacycline. Started Oct 2013; status: completed.
02
Drugs
fluconazoleibuprofen
03
Conditions
mycosespatent ductus arteriosus (PDA)
Beyond the preview
Go deeper on 2013-003611-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003611-21.